Kidney allograft survival after acute rejection, the value of follow-up biopsies.
about
Proteomics for rejection diagnosis in renal transplant patients: Where are we now?Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profilingThe Complement System and Antibody-Mediated Transplant RejectionGene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.Isolated endarteritis and kidney transplant survival: a multicenter collaborative study.Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal TransplantationAssessment of Arterial Stiffness, Volume, and Nutritional Status in Stable Renal Transplant Recipients.The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant InjuryEarly Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.Urinary cell mRNA profiles predictive of human kidney allograft statusImpact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.The value of long-term protocol biopsies after kidney transplantation.Complement as a multifaceted modulator of kidney transplant injury.The Interplay between inflammation and fibrosis in kidney transplantation.Through a glass darkly: seeking clarity in preventing late kidney transplant failureThe increasing clinical importance of alloantibodies in kidney transplantation.Impact of monocyte-macrophage inhibition by ibandronate on graft function and survival after kidney transplantation: a single-centre follow-up study over 15 years.A Machine Learning Approach Using Survival Statistics to Predict Graft Survival in Kidney Transplant Recipients: A Multicenter Cohort Study.Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.Ischaemic and inflammatory injury in renal graft from brain death donation: an update review.Trial design and endpoints in clinical transplant research.Surveillance biopsies after paediatric kidney transplantation: A review.Profiling risk for acute rejection in kidney transplantation: recipient age is a robust risk factor.Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center.Late kidney dysfunction in a kidney transplant recipientComparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes.Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice.Begin at the Beginning to Prevent the End.The impact of early and late acute rejection on graft survival in renal transplantation.Immediate and Catastrophic Antibody-Mediated Rejection in a Lung Transplant Recipient With Anti-Angiotensin II Receptor Type 1 and Anti-Endothelin-1 Receptor Type A Antibodies.Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.Essential role of microRNA-650 in the regulation of B-cell CLL/lymphoma 11B gene expression following transplantation: A novel mechanism behind the acute rejection of renal allografts.T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.The time dependency of renal allograft histology.Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-HLA Antibodies.Transplantation: Biomarkers in transplantation—the devil is in the detail.Renal Contrast-Enhanced Sonography Findings in a Model of Acute Cellular Allograft Rejection.Etiological analysis of graft dysfunction following living kidney transplantation: a report of 366 biopsies.Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation.
P2860
Q26751478-8BB92419-6A5F-4967-AD41-1BE224F1E18FQ26996813-F8EACAA5-8996-4E9E-BBFD-4610988FAC6BQ28087773-2F96A571-50E2-48E3-A547-D24C4ACE4C36Q33885388-9B60076F-AF39-4A6D-9DFB-07456A9A697BQ35550570-39A57EFE-BD24-4026-8F0E-E23C5B0765DFQ35677259-BE665606-6E20-434B-B177-14C03D8395AEQ36581199-98B88AE3-DEFD-4E77-83D5-A1E83E87AF59Q36782862-11AB2050-B41F-49CC-9822-3570C47C0FA6Q37346593-6506B8A4-B86F-4273-BAC5-AAD2263CDBFBQ37626743-DECD8234-C2A2-4203-A3D8-53FCF81722A8Q37660263-69471BDF-C38E-40C2-9530-2BE3C9C7871FQ38212981-A0B0AF2B-9AF6-4DA1-87A5-30010CAC6716Q38217273-7BD93965-B60F-45FE-A981-8A1ECCD723BDQ38225882-6ACB86F0-F86D-4ED4-A159-CE5C9B7ED8ABQ38237365-31230D17-980E-49F4-B87A-B495B8F348DCQ38258153-94CC3995-24CE-4CED-A783-8413ECCCA164Q38601054-A47C34B2-7582-433A-8E04-003187B719A6Q38615283-03EFC058-CE2B-43A0-A7C2-0E70EF747ACFQ38682284-F40D9BB4-0E73-44CE-B2FC-69E4764E8F12Q38690664-54A82577-2FBB-4B27-BC7D-3479859D8C67Q38691425-02C0E7EF-755C-4EED-8374-1161C1B959CBQ38866277-99CBF8CC-60D1-4925-9DE9-72C6A8603288Q39338311-6FD66ED9-092C-48C4-BD1C-8C3CBE2F82F6Q40777032-C7D47F00-6568-4A54-903B-D6A674EE0383Q41834576-F3364357-4327-41C1-A28D-AF75F14ADE04Q42160171-5F3E24F5-4923-4282-96F8-D5C1799BD06DQ42233729-EB9DB7D9-A729-4B61-87BC-B7220181DE6AQ42362413-31FBCE7D-68EC-4CB3-9726-088565D0CF72Q42395013-B8424702-E363-4B24-AC68-C0A5BE44D280Q43216209-AC7C332C-6425-4DE8-9441-1E4356D68EBEQ44797161-79DA4FCD-EBA1-4D4D-8F53-76E3539DFA2DQ46493273-1D6EBADD-3057-4360-948B-7CB58FFCFE4CQ47104864-36A9F7BF-CC77-4A0B-A201-03F41A537682Q47595221-69EBB590-577D-4BB7-BCD7-976181A4C131Q48162490-79DF27F4-9FA9-4465-A54A-C2E1EE84E0A7Q50247701-92278473-E4C9-4B2B-A0CB-15AEE2C12D76Q50969814-BCFB5C67-5CAD-438B-8696-00CFD93F5F71Q51627165-6C6B0670-4509-4565-A301-BCD3C82425A8Q52605491-DD4E4A69-C987-4D7F-83A1-A3BCA4F77A9FQ52656964-BC7AAC71-47BA-4E7E-BF0D-B5668A89FC4F
P2860
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
@en
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
@nl
type
label
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
@en
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
@nl
prefLabel
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
@en
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
@nl
P2093
P2860
P356
P1476
Kidney allograft survival after acute rejection, the value of follow-up biopsies.
@en
P2093
J P Grande
M D Stegall
M T Keddis
P2860
P304
P356
10.1111/AJT.12370
P407
P577
2013-07-19T00:00:00Z